BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24068741)

  • 1. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
    Berry SE; Andruszkiewicz P; Chun JL; Hong J
    Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
    Albesa M; Ogrodnik J; Rougier JS; Abriel H
    Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Cardiomyocytes From Vascular Adventitia-Resident Stem Cells.
    Mekala SR; Wörsdörfer P; Bauer J; Stoll O; Wagner N; Reeh L; Loew K; Eckner G; Kwok CK; Wischmeyer E; Dickinson ME; Schulze H; Stegner D; Benndorf RA; Edenhofer F; Pfeiffer V; Kuerten S; Frantz S; Ergün S
    Circ Res; 2018 Aug; 123(6):686-699. PubMed ID: 30355234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
    Chun JL; O'Brien R; Berry SE
    Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
    Mareedu S; Fefelova N; Galindo CL; Prakash G; Mukai R; Sadoshima J; Xie LH; Babu GJ
    JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
    Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
    Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
    Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras.
    Gonzalez JP; Kyrychenko S; Kyrychenko V; Schneider JS; Granier CJ; Himelman E; Lahey KC; Zhao Q; Yehia G; Tao YX; Bhaumik M; Shirokova N; Fraidenraich D
    Stem Cells; 2017 Mar; 35(3):597-610. PubMed ID: 27734557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
    van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
    FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
    Weir AP; Morgan JE; Davies KE
    Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
    Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
    Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
    Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
    J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.